Equivalent cross-relaxation rate imaging of breast cancer

Journal of Magnetic Resonance Imaging

Volumn 20, Issue 1, 2004, Pages 56-65

  Yuen, Sachiko ^a,e   Yamada, Kei ^a   Kinosada, Yasutomi ^b   Matsushima, Shigeru ^c   Nakano, Yasuhiko ^d   Goto, Mariko ^a   Nishimura, Tsunehiko ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d MATSUSHITA MEMORIAL HOSPITAL   (Japan)

^e SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Breast cancer; Dynamic MRI; Equivalent cross relaxation rate; Feasibility study (phase I); Fibrosis; Off resonance saturation transfer

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST DISEASE; BREAST FIBROSIS; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR GROWTH;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; SUBTRACTION TECHNIQUE;

EID: 3042793770     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20088     Document Type: Article

References (35)

1. Moran PR, Hamilton CA. Near-resonance spin-lock contrast. Magn Reson Imaging 1995;13:837-846.
2. Ulmer JL, Mathews VP, Hamilton CA, Elster AD, Moran PR. Magnetization transfer or spin lock? An investigation of off-resonance saturation pulse imaging with varying frequency offset. AJNR Am J Neuroradiol 1996;17:805-819.
3. Era S, Sogami M, Kinosada Y, Matsushima S, Kato K, Nagai N. Magnetization transfer in protein solution gel and polymer gel. In: Saito H, Webb GA, editors. Proceedings of the International Workshop on Magnetic Resonance/Spectroscopy in Food Science, 1997. p 107-110.
4. 1H NMR study. J Peptide Res 1997;50:465-474.
5. Matsushima S, Sasaki F, Kinosada Y, et al. Saturation transfer ratio imaging in invasive ductal carcinoma of the breast. Magn Reson Imaging 2000;18:379-385.
6. Callicott C, Thomas JM, Goode AW. The magnetization transfer characteristics of human breast tissues: an in vitro NMR study. Phys Med Biol 1999;44:1147-1154.
7. Akasaka K, Ishima R, Shibata S. Proton spin relaxation in biopolymers at high magnetic field. Physica B Condensed Matter 1990;164:163-179.
8. Akasaka K. Longitudinal relaxation of protons under cross saturation and spin diffusion. J Magn Reson 1981;45:337-343.
9. Sogami M, Era S, Kinosada Y, et al. Basic studies on the equivalent cross-relaxation rate imaging (equivalent CRI)-phantom studies. NMR Biomed 2001;14:367-375.
10. Matsushima S, Takasu A, Inai Y, Hirabayashi T, et al. Equivalent cross-relaxation rate imaging in the synthetic copolymer gels and invasive ductal carcinoma of the breast. Magn Reson Imaging 2002;20:285-293.
11. Aaltomaa S, Lipponen P, Eskelinen M, et al. Histological assessment of the prognostic factors in female breast cancer. Oncology 1992:49:1-8.
12. Aaltomaa S, Lipponen P, Eskelinen M, et al. Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer. Int J Cancer 1991;49:886-892.
13. Kimijima I, Ohtake T, Sagara H, Watanabe T, Takenoshita S. Scattered fat invasion: an indicator for poor prognosis in premenopausal, and for positive estrogen receptor in postmenopausal breast cancer patients. Oncology 2000;59:25-30.
14. Carlomagno C, Perrone F, Lauria R, et al. Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancer. Oncology 1995;52:272-277.
15. Hasebe T, Mukai K, Tsuda H, Ochiai A. New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus. Pathol Int 2000;50: 263-272.
16. Hasebe T, Tsuda H, Hirohashi S, et al. Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients. Breast Cancer Res Treat 1998;49:195-208.
17. Colpaert C, Vermeulen P, Van Beest P, et al. Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breast cancer patients. Histopathology 2001;39:416-425.
18. Colpaert C, Vermeulen P, Jeuris W, et al. Early distant relapse in 'node-negative' breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour. J Pathol 2001;193:442-449.
19. American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS) atlas, 4th edition. Reston, VA: American College of Radiology; 2003.
20. Zhang Y, Fukatsu H, Naganawa S, et al. The role of contrast-enhanced MR mammography for determining candidates for breast conservation surgery. Breast Cancer 2002;9:231-239.
21. Tillman GF, Orel SG, Schnall MD, Schultz DJ, Tan JE, Solin LJ. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol 2002;15:3413-3423.
22. Belli P, Costantini M, Romani M, Marano P, Pastore G. Magnetic resonance imaging in breast cancer recurrence. Breast Cancer Res Treat 2002;73:223-235.
23. Dvorak AM, Kohn S, Morgan ES, et al. The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukoc Biol 1996;59:100-115.
24. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement pattern on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996;200:639-649.
25. Byckley DL, Drew PJ, Mussurakis S, et al. Microvessel density in invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J Magn Reson Imaging 1997;7:461-464.
26. Knopp MV, Sinn EWHP, Mattern J, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999;10:260-266.
27. Flickinger FW, Allison JD, Sherry RM, Wright JC. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MR1. Magn Reson Imaging 1993;11: 617-620.
28. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101-110.
29. Gilles R, Zafrani B, Guinebretiêre J-M, et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology 1995; 196: 415-419.
30. Hulka CA, Smith BL, Sgroi DC, et al. Benign and malignant breast lesions: differentiation with echo-planar MR imaging. Radiology 1995;197:33-38.
31. Mussurakis S, Buckley DL, Horsman A. Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. Radiology 1997;302:317-321.
32. Mussurakis S, Buckley DL, Horsman A. Dynamic MR imaging of invasive breast cancer: correlation with tumour grade and other histological factors. Br J Radiol 1997;70:446-451.
33. Matsubayashi R, Matsuo Y, Edakuni G, Satoh T, Tokunaga O, Kudo S. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 2000;217:841-848.
34. Nunes LW, Schnall MD, Orel SG. Update of breast MR imaging architectural interpretation model. Radiology 2001;219:484-494.
35. Hochman MG, Orel SG, Powell CM, Schnall MD, Reynolds CA, White LN. Fibroadenomas: MR imaging appearances with radiologic-histopathologic correlation. Radiology 1997;204:123-129.